Startups
Inotek Pharmaceuticals Corporation is a private development-stage pharmaceutical company that has several products in development targeting oncology, cardiovascular, and inflammatory diseases.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 3, 2017 | Two biotech stocks crash on first trading day of the year | Lexington, Massachusetts-based Inotek took a 68 percent hit for its lead candidate trabodenoson, in development for patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH). The drug was reportedly well tolerated, but it... |
| Jun 29, 2016 | The biotech IPO feast flags as investors lose their appetite for R&D risk | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. But from 2013 through 2015 generalist investors got over their fears and jumped into one of the hottest stock games on the planet. Fund... |
| Sep 27, 2013 | Inotek snags $21M for PhII glaucoma drops | Lexington, MA's Inotek Pharmaceuticals has pulled down a $21 million round to advance its lead product, designed to ease in-eye pressure for glaucoma patients. Inotek's eye drop, dubbed trabodenoson, works in tandem with glaucoma therapy la... |
| Two biotech stocks crash on first trading day of the year | Lest we forget how brutal the biotech sector can be, two microcap companies had their share prices slashed close to 70 percent on Tuesday — the first trading day of 2017. Inotek Pharmaceuticals and Agile Therapeutics were independently obli... |
Reviews 0
FAQ about Inotek Pharmaceuticals
What has the press written about Inotek Pharmaceuticals?
Parsers VC has collected 5 articles mentioning Inotek Pharmaceuticals, among them “Two biotech stocks crash on first trading day of the year” (Jan 3, 2017) and “The biotech IPO feast flags as investors lose their appetite for R&D risk” (Jun 29, 2016).
Is Inotek Pharmaceuticals still active?
Yes, Inotek Pharmaceuticals is active; its latest activity on Parsers VC dates from May 18, 2018.